Referenciák 1.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10. Nathwani D, Eckmann C, Lawson W, et al. Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and oft tissue infections. Clin Microbiol Infect. 2014;20(10):993-1000.

11. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-77.

12. IDSA. Promoting Antimicrobial Stewardship in Human Medicine. Available at: http://www.idsociety.org/stewardship_policy/. Accessed 21 Apr 2016.

13. Urbina O, Ferrández O, Espona M, Salas E, Ferrández I, Grau S. Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections. Drug Des Devel Ther. 2013;7:243-65.

1. Sivextro alkalmazási előírás, 2016. január 13.

2. ECDC. Antimicrobial resistance surveillance in Europe 2014. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2015. Available at: http://ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-europe-2014.pdf. Accessed 21 Apr 2016.

3. Food and Drug Administration. Guidance for Industry. Acute bacterial skin and skin structure infections: Developing drugs for treatment. October 2013. Available at http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatory-Information/Guidances/ucm071185.pdf. Accessed 13 Jan 2015.

4. Dryden MS. Complicated skin and soft tissue infection. J Antimicrob Chemother. 2010;65 Suppl 3:iii35-44.

5. Rajan S. Skin and soft-tissue infections: Classifying and treating a spectrum. Cleve Clin J Med. 2012;79(1):57-66.

6. Elixhauser A, Steiner C. Infections with methicillin-resistant Staphylococcus aureus (MRSA) in U.S. hospitals, 1993–2005. HCUP Statistical Brief #35. July 2007. Agency for Healthcare Research and Quality, Rockville, MD, USA. Available at: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb35.pdf. Accessed 5 April 2016.

7. Edelsberg J, Taneja C, Zervos M, et al. Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis. 2009;15:1516-18.

8. Ostermann H, Blasi F, Medina J, Pascual E, McBride K, Garau J; for REACH study group. Resource use in patients hospitalized with complicated skin and soft tissue infections in Europe and analysis of vulnerable groups: the REACH study. J Med Econ. 2014;17(10):719-29.

9. Eckmann C, Lawson W, Nathwani D, et al. Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus: A plea for implementation of early switch and early discharge criteria. Int J Antimicrob Agents. 2014;44(1):56-64.